Micin vs Doximity
Side-by-side comparison of AI visibility scores, market position, and capabilities
MICIN raised 10B+ yen (~$99M) through Series C; its Curon telemedicine platform serves 5,000+ Japan clinics; digital therapeutics and clinical development tools round out a multi-pillar health tech platform.
About
MICIN is a Tokyo-based healthcare technology company founded in 2015 that operates at the intersection of telemedicine, digital therapeutics, and clinical development. Its flagship platform, Curon, enables online medical consultations — allowing patients in Japan to book appointments, receive virtual consultations, pay, and receive prescription delivery entirely online. Launched in 2016, Curon is now used by more than 5,000 clinics and hospitals across Japan.
Doximity (NYSE: DOCS), professional network for US physicians with 2M+ verified clinicians; telehealth, medical news, and career tools monetized via pharmaceutical digital marketing.
About
Doximity is a professional network and digital health platform purpose-built for licensed physicians and other healthcare professionals in the United States. With more than two million verified clinicians on the platform — representing the majority of practicing US physicians — Doximity has established itself as the dominant professional network for doctors, providing identity-verified peer connections, specialty-specific news feeds, medical journal access, and career management tools including a physician job board and CV builder. The verification layer distinguishes Doximity from general professional networks and makes it the standard reference for confirming physician credentials and contact information across the healthcare industry.
AI Visibility Head-to-Head
Key Details
Capabilities & Ecosystem
Capabilities
Also Compare
Track AI Visibility in Real Time
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.